Article
Proteomic and In Silico Analyses Highlight Complement System’s Role in Bladder Cancer Immune Regulation
16 Apr 2025
Abstract excerpt
Background and Objectives: Bladder cancer (BLCA), intimately associated with the immune system, represents a substantial global health burden due to its high recurrence rates and limited therapeutic effectiveness. Although immunotherapy shows promise, challenges persist due to the lack of reliable therapeutic targets. This study aims to investigate potential immune-related biomarkers that could influence the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
